Answers are grounded in this paper and cite their sources.
Phytochemical investigation finds novel chalcone-terpene hybrids reducing carbapenemase activity, suggesting new treatment avenues.
species. Phytochemical investigation resulted in the isolation of nine compounds, including three unreported natural products. Of these, fissisteifolin, a quinone, features a unique tetracyclic structure deriving from a chalcone and an uncommon monoterpene. Finally, fissistidin, an original chalcone-sesquiterpene dimer, exhibited 83% reduction in KPC-2 enzyme activity, establishing its potential as a candidate for developing novel carbapenemase inhibitors.
No takes yet. Share an insight, caveat, or question.
Martínez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: